Biogen Still Not Disclosing Which Exec Has Coronavirus Infection
Four Execs Attended Investor Conference
Executive Summary
Public health officials in Massachusetts say Biogen company meeting is source of 70 cases in the state.
You may also be interested in...
From Biogen To Bayer: Coronavirus A Stress Test For Pharma
When a global pandemic hits and local rules over personal movement are highly fluid and constantly updated, two pharma firms with a global footprint have faced unprecedented tests.
Gilead's China Remdesivir Patents Confirmed, Generics Firms Cautioned
As the front-runner antiviral in the fight against the coronavirus gets increasingly positive attention in China, officials take action to keep the originator front and center and domestic copycats at bay.
Corbus And Janux Lead Q1’s Small-Cap Winners
Corbus has presence in both antibody drug conjugates and obesity, and was the stand-out small-cap target for investors with a fivefold increase in its share price in Q1.